Skip to content

Perphenazine

DRUG15 trials

Sponsors

Universitair Medisch Centrum Utrecht, National Institute of Mental Health (NIMH), BioLineRx, Ltd., Paul Saenger, Janssen Scientific Affairs, LLC

Conditions

Anxiety DisordersBipolar DisorderCocaine DependenceDementiaDepressionHealthyIschemic Stroke, AcutePerioperative Optimization

Phase 1

Phase 2

Phase 3

Phase 4

CATIE- Schizophrenia Trial
CompletedNCT00014001
National Institute of Mental Health (NIMH)Schizophrenia
Start: 2000-12-31End: 2004-12-31Target: 1600Updated: 2015-06-17
Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
CompletedNCT00802100
National Institute of Mental Health (NIMH)Schizophrenia
Start: 2008-12-31End: 2009-10-31Updated: 2013-02-08
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
CompletedNCT01157351
Janssen Scientific Affairs, LLCSchizophrenia
Start: 2010-05-31End: 2013-12-31Updated: 2015-04-24
Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
WithdrawnNCT01193166
Ortho-McNeil Janssen Scientific Affairs, LLCSchizophrenia
Start: 2010-08-31End: 2012-09-30Updated: 2013-07-08
Lurasidone Effects on Tissue Glutamate in Schizophrenia
CompletedNCT02199743
University of Texas Southwestern Medical CenterSchizoaffective Disorder, Schizophrenia
Start: 2013-02-28End: 2016-06-30Updated: 2021-03-01
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
CompletedNCT02307396
Technical University of MunichSchizoaffective Disorders, Schizophrenia, Schizophrenia and Disorders With Psychotic Features
Start: 2015-02-01End: 2016-06-22Updated: 2018-10-11
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for schizophrenia compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.
RecruitingCTIS2023-506602-39-00
Universitair Medisch Centrum Utrechtschizoaffective disorder, schizophrenia, schizophrenifom disorder
Start: 2024-08-01Target: 310Updated: 2025-03-04

Unknown Phase

Related Papers

The Journal of Clinical Psychiatry2020-03-165 citations

13 more papers not shown